Revance Therapeutics (RVNC)
$22.47
0.11 (0.47%)
RVNC Stock Quote Delayed 15 Minutes
Previous Close
$22.47
Market Cap
826.35M
PE Ratio
-5.56
EPS
-4.04
Volume (Avg. Vol.)
628,800
Day's Range
22.10 - 22.68
52-Week Range
9.88 - 23.43
Dividend & Yield
N/A (N/A)
RVNC Stock Predictions, Articles, and Revance Therapeutics News
Revance Therapeutics Inc Is Set to Shake Up the Botox Market
RVNC has an edge with its formulation of Botox: it lasts longer. Given the little innovation in the botulinim toxin market, Revance has a real chance to succeed.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
